3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
82
Pancreatic Neoplasms
33
Stomach Neoplasms
32
Rectal Neoplasms
23
Colonic Neoplasms
22
Neoplasms
20
Neoplasm Metastasis
18
Esophageal Neoplasms
16
Cholangiocarcinoma
14
Burkitt Lymphoma
13
Adenocarcinoma Of Esophagus
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Carcinoma, Non-Small-Cell Lung
12
Biliary Tract Neoplasms
12
Adenocarcinoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Ovarian Neoplasms
6
Gastrointestinal Neoplasms
6
Leukemia, Biphenotypic, Acute
5
Gallbladder Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Endometrial Neoplasms
5
Advanced Solid Tumors
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lung Neoplasms
4
Leukemia
4
Carcinoma, Renal Cell
4
Appendiceal Neoplasms
4
Urinary Bladder Neoplasms
3
Interventions
tremelimumab
4
Ipilimumab
4
lenvatinib
3
durvalumab
3
Nivolumab
3
pembrolizumab
2
balstilimab
2
Pemetrexed
2
Carboplatin
2
Bevacizumab
2
spartalizumab
1
relatlimab
1
poly ICLC
1
osimertinib
1
cemiplimab
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Standard of Care
1
Platinum
1
Peptides
1
Paclitaxel
1
Opdualag
1
Docetaxel
1
Capecitabine
1
Blood Specimen Collection
1
Axitinib
1
Antibodies, Bispecific
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diabetes Mellitus, Insulin-Dependent, 12
×
Leucovorin
×
1 year
×
Clear all
No trials found.